Brazil is widely recognised for achieving one of the most significant declines in smoking prevalence globally over the past three decades. Comprehensive tobacco control measures, including advertising restrictions, smoke-free laws, warning labels, taxation, and cessation support, have contributed to sustained reductions in cigarette consumption and tobacco-related disease. At the same time, Brazil maintains one of…
The latest compromise text under the Cypriot Presidency in the revision of the EU Tobacco Taxation Directive represents a cautious but meaningful shift in the debate over nicotine pouch excise. While the proposal does not fully resolve concerns around proportionality and risk alignment, it acknowledges a central empirical reality: national taxation of nicotine pouches varies…
As nicotine pouches gain market presence in the United States, regulators must understand not only who is using these products, but where and under what conditions they are being purchased. A recent peer-reviewed study published in Preventive Medicine provides new empirical evidence by examining urban–rural differences in nicotine pouch sales, pricing, and flavour preferences across…
Recent market analyses from multiple industry research groups indicate that nicotine pouches are among the fastest-growing segments within the broader nicotine alternatives category. Reports from Fact.MR, Euromonitor International, Grand View Research, and other sector analysts project sustained global expansion over the coming decade, driven by regulatory pressure on combustible cigarettes, product innovation, and widening consumer…
The U.S. Food and Drug Administration’s ongoing review of modified risk tobacco product (MRTP) applications for ZYN nicotine pouches represents a pivotal moment in the regulation of non-combustible nicotine. At stake is not whether nicotine products are “safe,” but whether regulators will permit carefully constrained, evidence-based communication about relative risk compared with cigarette smoking. The…
Nicotine policy is increasingly being shaped not only by legislators and regulators, but by the channels through which products are made available to adults. In several countries, pharmacies have emerged as a focal point in this debate, acting either as formal gatekeepers of access or as trusted retail environments for smoke-free nicotine products. How pharmacists…
The European Commission has confirmed that the EU Tobacco Policy Expert Group (TPEG) will formally conclude its mandate, even as work on the next revision of the Tobacco Products Directive (TPD) continues. While the end of a technical advisory body may appear procedural, it raises important questions about how expertise, evidence, and stakeholder input will…
Nicotine pouches continue to expand across multiple markets, even as regulatory scrutiny intensifies and public debate grows more polarised. This sustained growth is not accidental, nor is it driven by novelty alone. It reflects a convergence of behavioural, commercial, and policy dynamics that are reshaping how adult nicotine users move away from combustible cigarettes. For…
Nicotine pouches are no longer a niche or experimental category. Retail and market indicators now show sustained growth across major U.S. convenience channels, reinforcing a reality that regulators globally can no longer ignore: consumer uptake is happening faster than policy alignment. Recent U.S. retail reporting highlights accelerating sales, expanding shelf presence, and increasing manufacturer investment…
Nicotine pouches are increasingly discussed as a distinct category within the broader harm-reduction landscape, raising important questions about how they should be regulated, communicated, and positioned relative to smoking cessation tools. A recent commentary in The Lancet Public Health provides a timely and balanced lens through which to assess these questions, particularly as policy debates…